Biomedtracker Q3 2017 Outlook Report

Biomedtracker Q3 2017 Outlook Report

  • August 2017 •
  • Report ID: 5168617 •
  • Format: PDF
In this report, we cover catalysts from 21 drugs expected to occur in Q3 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. At the end of this report, we have included a list of Large Impact catalysts through Q3 2017.